Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafna Yahav

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2026
Cat Scratch Disease Encephalitis: New Insights into Rate, Clinical Features, and Long-Term OutcomesMichal Yakubovsky, Laliv Kadar, Eugene Katchman, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBaAnna L Goodman, Nicholas Easom, Dana Bielopolski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Communications Medicine|December 11, 2024
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infectionJohn Karlsson Valik, Christian G Giske, Badrul Hasan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2022
Characteristics of long-COVID among older adults: a cross-sectional studyVered Daitch, Dana Yelin, Muhammad Awwad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Infectious Diseases and Therapy|April 3, 2025
West Nile Virus Outbreak in Israel 2024 Compared with Previous Seasons: A Retrospective StudyGuy Katzenellenbogen, Michal Canetti, Ili Margalit, et al.
Emerging Infectious Diseases|June 22, 2023
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022Roni Biran, Regev Cohen, Talya Finn, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2026
Cat Scratch Disease Encephalitis: New Insights into Rate, Clinical Features, and Long-Term OutcomesMichal Yakubovsky, Laliv Kadar, Eugene Katchman, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBaAnna L Goodman, Nicholas Easom, Dana Bielopolski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Communications Medicine|December 11, 2024
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infectionJohn Karlsson Valik, Christian G Giske, Badrul Hasan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 3, 2022
Characteristics of long-COVID among older adults: a cross-sectional studyVered Daitch, Dana Yelin, Muhammad Awwad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Infectious Diseases and Therapy|April 3, 2025
West Nile Virus Outbreak in Israel 2024 Compared with Previous Seasons: A Retrospective StudyGuy Katzenellenbogen, Michal Canetti, Ili Margalit, et al.
Emerging Infectious Diseases|June 22, 2023
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022Roni Biran, Regev Cohen, Talya Finn, et al.
Pageof 24